Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy

Glioblastoma (GBM), the most aggressive form of brain cancer, has witnessed very little clinical progress over the last decades, in part, due to the absence of effective drug delivery strategies. Intravenous injection is the least invasive drug delivery route to the brain, but has been severely limi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregory, Jason V., Kadiyala, Padma, Doherty, Robert, Cadena, Melissa, Habeel, Samer, Ruoslahti, Erkki, Lowenstein, Pedro R., Castro, Maria G., Lahann, Joerg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655867/
https://www.ncbi.nlm.nih.gov/pubmed/33173024
http://dx.doi.org/10.1038/s41467-020-19225-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655867/
https://www.ncbi.nlm.nih.gov/pubmed/33173024
http://dx.doi.org/10.1038/s41467-020-19225-7

Ejemplares similares